Nabis Corporate Presentation

CANNOVA MEDICAL - INNOVATIVE TECHNOLOGY NABIS TM SUBLINGUAL STRIP bl O First-of-its-kind alternative cannabis consumption method Faster absorption into the bloodstream via under-the- tongue insertion Patent-protected production process combines formulations with water-soluble cannabinoids and natural active ingredients LOWA OM BESON w MA FIL 75 275 CAN CA CANNONA 2 CBD CBT CBE THC CANNOVA NOVAJET PRO Innovative printing machine used to produce customized strips with ability to infuse different quantities of cannabinoids & natural substances CSE: NAB Allows for development of highly measured, accurate and tailored strips Continued development in Israel of innovative, alternative solutions for cannabis consumption and other technology solutions that will shape the industry In consideration for the 49% interest, Nabis will pay Cannova US $1,000,000 and will issue to Cannova an aggregate of 5,911,111 common shares of Nabis ("Common Shares"). To exercise its option to acquire the remaining 51% interest, Nabis must make a nominal cash payment and issue to the Cannova shareholders 7,388,888 Common shares, which will be held in escrow and released subject to Cannova achieving certain performance milestones.

View entire presentation